|
The Program in Cancer Immunology and Immunotherapy brings together experts in the fields of immunobiology, medicine, surgery and pathology to explore the interaction between the immune system and cancer.
Building on their findings, program members are advancing new strategies that use the exquisite specificity of the body's natural defenses to destroy tumors with minimal toxicity to healthy tissues.
Program researchers work between the lab and the clinic investigating the hummoral and cellular arms of the immune system for new treatment opportunities. Their efforts are advancing:
- novel treatments such as patient-specific vaccines and cell-based therapies that incite a patient's own immune defenses to attack his or her cancer
- new targets for today's therapeutic monoclonal antibodies
- the potential of cytokines and other effector molecules as therapeutic agents
Current areas of research include:
Cell-based Immunotherapy of Cancer
New Approaches for Monitoring Immune-tumor Interactions
T Cells, B Cells, Dendritic Cells and Mast Cells and their Interactions with Tumors
Program Directors
Mark Davis, PhD
Edgar Engleman, MD
|
